Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
3.390
-0.010 (-0.29%)
At close: Sep 16, 2026, 4:00 PM EDT
3.390
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $844.75 million as of September 16, 2026. Its market cap has decreased by -46.32% in one year.
Market Cap
844.75M
Enterprise Value
845.42M
1-Year Change
-46.32%
Ranking
Category
Stock Price
$3.39
ChartMarket Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $844.75M, an increase of 248.06%. That is a compound annual growth rate of 10.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 844.75M | -40.36% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 902.48M |
| Olema Pharmaceuticals | 900.35M |
| Theravance Biopharma | 884.18M |
| Lexicon Pharmaceuticals | 881.01M |
| Geron | 880.19M |
| Immix Biopharma | 873.50M |
| Avalo Therapeutics | 867.73M |
| Rigel Pharmaceuticals | 847.13M |